Significance of HOX11L2/TLX3 expression in children with T-cell acute lymphoblastic leukemia treated on Children's Cancer Group protocols.
N G
NG
Gottardo
P A
PA
Jacoby
H N
HN
Sather
G H
GH
Reaman
D L
DL
Baker
U R
UR
Kees
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D020732:Cytogenetic Analysis; D005500:Follow-Up Studies; D015972:Gene Expression Regulation, Neoplastic; D018398:Homeodomain Proteins / Q000096:biosynthesis* / Q000235:genetics*; D006801:Humans; D007223:Infant; D015513:Oncogene Proteins / Q000096:biosynthesis* / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000235:genetics*; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome
D018398:Homeodomain Proteins; D015513:Oncogene Proteins; C489494:TLX3 protein, human